Calif. governor vetoes biosimilars bill

10/14/2013 | New York Times (tiered subscription model), The

California Gov. Jerry Brown vetoed a bill that would limit the use of biosimilars by requiring pharmacists to notify doctors and patients if a biosimilar was being substituted for the prescribed drug, which the bill said could be done in cases in which the FDA says the biosimilar is interchangeable with the brand-name drug. "This requirement, which on its face looks reasonable, is for some reason highly controversial," Brown's veto message said. A notification requirement was premature because the FDA has yet to decide on the standards for the biosimilars' interchangeability with the original products, Brown said.

View Full Article in:

New York Times (tiered subscription model), The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Catheter Engineer Manager
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD